SavedAdd your journal

Journals / Çukurova Üniversitesi Tıp Fakültesi Dergisi / 2001 / Cilt: 26 - Sayı: 2

Evaluation of serum TNF-alpha levels in heart failure

Kalp yetersizliğinde tümör nekroz faktör-alfa düzeyinin değerlendirilmesi

Abdi BOZKURT
Ayhan USAL
Mustafa DEMİRTAŞ
Abdullah CANATAROĞLU
Pages
87–91
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RESULTS: Levels of serum TNF-alpha were found as 70.848+91.800 pg/ml in the patients with HF and 19.915±5.567 pg/ml in the healthy controls (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSE: Increased serum level of tumor necrosis factor-alpha (TNF-alpha) in heart failure (HF) is suggested as a prognostic marker of the disease.-The detection of serum levels of TNF-alpha in ischemic and idiopathic dilated cardiomyopathy and the evaluation of relationbetween serum TNF-alpha levels and ejection fraction (EF) are aimed in this study.
📊
Key Findings & Data:METHODS: Thirty patients (16 male, 14 female; mean age 49.0±14.58 years) with HF and 20 healthy controls (10 male, 10 female; mean age 53.85±9.87 years) were included in the study.
💡
Conclusion & Impact:RESULTS: Levels of serum TNF-alpha were found as 70.848+91.800 pg/ml in the patients with HF and 19.915±5.567 pg/ml in the healthy controls (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

PURPOSE: Increased serum level of tumor necrosis factor-alpha (TNF-alpha) in heart failure (HF) is suggested as a prognostic marker of the disease.-The detection of serum levels of TNF-alpha in ischemic and idiopathic dilated cardiomyopathy and the evaluation of relationbetween serum TNF-alpha levels and ejection fraction (EF) are aimed in this study. METHODS: Thirty patients (16 male, 14 female; mean age 49.0±14.58 years) with HF and 20 healthy controls (10 male, 10 female; mean age 53.85±9.87 years) were included in the study. RESULTS: Levels of serum TNF-alpha were found as 70.848+91.800 pg/ml in the patients with HF and 19.915±5.567 pg/ml in the healthy controls (p

Özet

AMAÇ: Kalp yetersizliğinde (KY) tümör nekroz faktör-alfa (TNF-alfa) serum düzeyinin artmasının hastalığın prognostik belirleyicilerinden biri olduğu belirtilmektedir. Bu çalışmada, iskemik ve idiyopatik dilate kardiyomiyopatili hastalarda serum TNF-alfa düzeyinin saptanması ve bu düzeyin hastaların ejeksiyon fraksiyonu (EF) ile ilişkisinin olup olmadığının değerlendirilmesi amaçlandı. YÖNTEM: Çalışmaya KY olan 30 (16 erkek, 14 kadın; yaş ortalaması 49.0±14.58 yıl) hasta ile kontrol grubu olarak 20 (10 erkek, 10 kadın; yaş ortalaması 53.85±9.87yıl) sağlıklı birey alındı. SONUÇLAR: KY olan hastaların ortalama TNF-alfa düzeyleri 70.848±91.800 pikogram/mililitre (pg/ml), kontrol grubunun ise 19.915±5.567 pğ/ml olarak tesbit edildi (p

🔖

Cite This Article

BOZKURT, A., USAL, A., DEMİRTAŞ, M., CANATAROĞLU, A. (2022). Evaluation of serum TNF-alpha levels in heart failure. Çukurova Üniversitesi Tıp Fakültesi Dergisi, Cilt: 26 - Sayı: 2, 87–91. https://ajindex.com/articles/486108

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Baig MK, Mahon M, McKenna WJ, et al: Managing the patient with heart failure. Am Heart J 1998; 135:216-230
  2. Barath P, Fishbein MC, Cao J, et al: Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990;65: 297-302
  3. Beutler B, Krochin N, Milsark IW, et al: Control of cachectin (tumor necrosis factor) synthesis: Mechanism of endotoxin resistance. Science 1986;232: 977-980
  4. Bryant D, Becker L, Richardson J, et al: Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor. Circulation 1998;97:1375- 1380
  5. Dutka DP, Elborn JS, Delamera F, et al: Tumor necrosis factor alpha in severe congestive cardiac failure. Br Heart J 1993;70:141-143
  6. Ekmekçi A: Patolojik yeni yapılanma: Remodeling. Konjestif Kalp Yetmezliği Tedavisine Patofizyolojik Yaklaşım, Ekmekci A (ed.s), İstanbul, 1996, 48
  7. Fuchs D, Samsonow M, Tilz GP, et al. Stimulated cellular immune system in patients with congestive heart failure. Eur J Clin Chem Clin Biochem 1993;31:111-114
  8. Giroir BP, Johnson JH, Brown T, et al: The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 1992;90: 693-698
  9. Habib FM, Springall DR, Davies GJ; et al: Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 1996;347: 1151- 1155
  10. Hattler BG, Zeevl A, Oddis CV, et al: Cytokine induction during cardic surgery: analysis of TNF-alpha expression pre- and postcardiopulmonary by-pass. J Card Surg 1995;10:418-422
  11. Katz SD, Rao R, Berman JW, et al: Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Circulation 1994;90:12-16
  12. Krown KA, Page MT, Nguyen C, et al: Tumor necrosis factor alpha- induced apopitosis in cardiac myocytes: involvement of the sphingolipid cascade in cardiac cell death. J Clin Invest 1996;98: 2854-2865
  13. Levine B, Kalman J, Mayer L, et al: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Eng J Med 1990;323:236- 241
  14. Marriot JG, Goldman JH, Keeling PJ, et al: Abnormal cytokine levels in idiopathic dilated cardiomyopathy correlate with prognosis. Heart 1995;75: 287-290
  15. Matsumori A, Yamada T, Suzuki H, et al: Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994;72: 561-566
  16. Mc Kee PA, Castelli WP, Mc Namara PM, et al: The natural history of congestive heart failure: The Framingham st